Whittier Trust’s Maravai LifeSciences MRVI Stock Holding History

Whittier Trust’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,179	Closed	-$10.2K	–	1563
2024 Q1	$10.2K	Buy	+1,179	New	+$7.98K	﹤0.01%	1267

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Whittier Trust's MRVI Position: Q2 2024 in Review

Whittier Trust sold out of Maravai LifeSciences (MRVI) in Q2 2024, closing a stake of 1,179 shares — an estimated $10.2K sold.

Whittier Trust first reported a position in MRVI in Q1 2024 and held it in 1 quarter. The position peaked at $10.2K in Q1 2024. 206 funds tracked by Wall St. Rank hold MRVI as of Q2 2024.

Whittier Trust reported no remaining Maravai LifeSciences position as of Q2 2024 after selling out during the quarter.
Whittier Trust sold 1,179 Maravai LifeSciences shares in Q2 2024, an estimated $10.2K.
Whittier Trust first reported a position in Maravai LifeSciences in Q1 2024 and held it in 1 quarter.
Whittier Trust's Maravai LifeSciences position peaked at $10.2K in Q1 2024.
206 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2024.

Based on Whittier Trust's 13F filing for Q2 2024, filed 29 Jul 2024.